Molecular origins of cancer: Molecular basis of colorectal cancer.
作者信息
Markowitz Sanford D, Bertagnolli Monica M
机构信息
Department of Medicine and Ireland Cancer Center, Case Western Reserve University School of Medicine and Case Medical Center, Cleveland, USA.
出版信息
N Engl J Med. 2009 Dec 17;361(25):2449-60. doi: 10.1056/NEJMra0804588.
Abstract
摘要
相似文献
1
Molecular origins of cancer: Molecular basis of colorectal cancer.
N Engl J Med. 2009 Dec 17;361(25):2449-60. doi: 10.1056/NEJMra0804588.
2
Molecular basis for stool-based DNA tests for colorectal cancer: a primer for clinicians.
Rev Gastroenterol Disord. 2002;2 Suppl 1:S12-9.
3
Tumor biology--colorectal cancer as an illuminating example.
Eur J Surg Suppl. 1991 May(561):9-13.
4
Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
BMC Bioinformatics. 2019 Apr 18;20(Suppl 4):119. doi: 10.1186/s12859-019-2687-7.
5
EYA4 Acts as a New Tumor Suppressor Gene in Colorectal Cancer.
Mol Carcinog. 2015 Dec;54(12):1748-57. doi: 10.1002/mc.22247. Epub 2015 Jan 25.
6
Revealing the intricacies of cancer.
Genome Biol. 2002;3(6):REPORTS4015. doi: 10.1186/gb-2002-3-6-reports4015. Epub 2002 May 13.
7
[Colon cancer: molecular markers].
Dtsch Med Wochenschr. 2005 Apr 8;130(14):880-2. doi: 10.1055/s-2005-865102.
8
Molecular genetics of colorectal cancer (part 1).
Clin Oncol (R Coll Radiol). 1997;9(1):14-9. doi: 10.1016/s0936-6555(97)80052-0.
9
Biochemical markers for colorectal cancer. Diagnostic and therapeutic implications.
Surg Clin North Am. 1993 Feb;73(1):85-102. doi: 10.1016/s0039-6109(16)45930-x.
10
[The long road from molecular biology to clinical practice in colorectal cancer].
Gastroenterol Hepatol. 2016 Aug-Sep;39(7):429-32. doi: 10.1016/j.gastrohep.2015.11.005. Epub 2016 Feb 2.
引用本文的文献
1
Can Salivary Biomarkers Serve as Diagnostic and Prognostic Tools for Early Detection in Patients with Colorectal Cancer? A Systematic Review.
Curr Issues Mol Biol. 2025 Aug 12;47(8):647. doi: 10.3390/cimb47080647.
2
Integrative multi-omics analysis identifies key genes and colocalized signals associated with colorectal cancer risk.
BMC Cancer. 2025 Aug 25;25(1):1372. doi: 10.1186/s12885-025-14798-2.
3
Bioinformatics mining and experimental validation of prognostic biomarkers in colorectal cancer.
Discov Oncol. 2025 Aug 22;16(1):1596. doi: 10.1007/s12672-025-03301-9.
4
The Anti-Inflammatory, Immunomodulatory, and Pro-Autophagy Activities of Probiotics for Colorectal Cancer Prevention and Treatment: A Narrative Review.
Biomedicines. 2025 Jun 25;13(7):1554. doi: 10.3390/biomedicines13071554.
5
Development of a prognostic prediction model based on damage-associated molecular pattern for colorectal cancer applying bulk RNA-seq analysis.
Sci Rep. 2025 Jul 16;15(1):25792. doi: 10.1038/s41598-025-10592-z.
6
Investigating the link between mutation and breast cancer in a Jordanian Arab population.
Front Oncol. 2025 Jun 27;15:1557341. doi: 10.3389/fonc.2025.1557341. eCollection 2025.
7
Colorectal polyps: pathophysiology, malignant potential, and advancements in therapeutic strategies.
Med Oncol. 2025 Jun 27;42(8):287. doi: 10.1007/s12032-025-02861-8.
8
A tumor-microvessel on-a-chip reveals a mechanism for cancer cell cluster intravasation.
iScience. 2025 Apr 24;28(6):112517. doi: 10.1016/j.isci.2025.112517. eCollection 2025 Jun 20.
9
Switching from messenger RNAs to noncoding RNAs, is a novel colorectal cancer diagnosis and treatment target.
World J Gastrointest Oncol. 2025 May 15;17(5):104076. doi: 10.4251/wjgo.v17.i5.104076.
10
Characteristics of the gut virome in patients with premalignant colorectal adenoma.
J Transl Med. 2025 May 28;23(1):597. doi: 10.1186/s12967-025-06404-7.
本文引用的文献
1
Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer.
J Natl Cancer Inst. 2009 Oct 7;101(19):1308-24. doi: 10.1093/jnci/djp280. Epub 2009 Sep 8.
2
Sensitive digital quantification of DNA methylation in clinical samples.
Nat Biotechnol. 2009 Sep;27(9):858-63. doi: 10.1038/nbt.1559. Epub 2009 Aug 16.
3
p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803.
Clin Cancer Res. 2009 Mar 15;15(6):2116-22. doi: 10.1158/1078-0432.CCR-08-2674. Epub 2009 Mar 10.
4
Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.
J Clin Oncol. 2009 Apr 10;27(11):1814-21. doi: 10.1200/JCO.2008.18.2071. Epub 2009 Mar 9.
5
Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study.
Gastroenterology. 2009 Apr;136(4):1251-60. doi: 10.1053/j.gastro.2008.12.050. Epub 2008 Dec 27.
6
Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection.
Ann Intern Med. 2009 Feb 3;150(3):162-9. doi: 10.7326/0003-4819-150-3-200902030-00005.
7
The genetics of the p53 pathway, apoptosis and cancer therapy.
Nat Rev Drug Discov. 2008 Dec;7(12):979-87. doi: 10.1038/nrd2656.
8
Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer.
Nat Genet. 2008 Dec;40(12):1426-35. doi: 10.1038/ng.262. Epub 2008 Nov 16.
9
Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample.
PLoS One. 2008;3(11):e3698. doi: 10.1371/journal.pone.0003698. Epub 2008 Nov 12.
10
Using predictive biomarkers to select patients with advanced colorectal cancer for treatment with epidermal growth factor receptor antibodies.
J Clin Oncol. 2008 Dec 10;26(35):5668-70. doi: 10.1200/JCO.2008.19.5024. Epub 2008 Nov 10.
Zotero 插件